Apoptosis Signaling in Tumor Therapy
- 1 December 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1028 (1), 150-156
- https://doi.org/10.1196/annals.1322.016
Abstract
Apoptosis, the cell's intrinsic program to death, plays a central role in physiological growth control and regulation of tissue homeostasis. Tipping the balance between cell death and proliferation in favor of cell survival may result in tumor formation. Also, killing of cancer cells by cytotoxic therapies currently used for treatment of cancer, for example, chemotherapy, gamma-irradiation, immunotherapy, or suicide gene therapy, largely depends on activation of apoptosis programs in cancer cells. Accordingly, failure to undergo apoptosis in response to anticancer therapy may result in cancer resistance. Further insights into the mechanisms regulating apoptosis in response to anticancer therapy and how cancer cells evade cell death may provide novel opportunities for drug development.Keywords
This publication has 37 references indexed in Scilit:
- Clustering of hypermethylated genes in neuroblastomaGenes, Chromosomes and Cancer, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Epigenetic changes in tumor Fas levels determine immune escape and response to therapyCancer Cell, 2002
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Molecular determinants of apoptosis induced by cytotoxic drugsKlinische Padiatrie, 1998
- A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck CarcinomaThe Journal of Experimental Medicine, 1997